FundedIQ
Biotechnology

Granza Bio: Funding, Investors & Team (Sep 2026)

Granza Bio is a company that specializes in creating cancer treatments that utilize the immune system of the human body.

granzabio.com LinkedIn San Francisco, United States 1-10 employees
Biopharma Biotechnology Medical Wellness B2B
Total raised
$7.1M
Rounds
1
Latest
Seed
Jul 2024

Granza Bio has raised $7.1M across 1 funding round on record, the most recent a Seed of $7.1M announced in Jul 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Granza Bio Company Profile and Key Stats

Total funding raised
$7.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$7.1M in Jul 2024
Employees
1-10
reported band
Headquarters
San Francisco, United States

Latest funding round on record: Jul 2024.

Granza Bio Funding Rounds

Date
Round
Amount
Seed
$7.1M

Granza Bio Founders and Leadership Team

Name
Role
Contact
Ashwin Jainarayanan
Founder
Locked

Contact details for the Granza Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Granza Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
16,485
$3.1M

Granza Bio's latest round of $7.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Granza Bio in Biotechnology and San Francisco

Companies Similar to Granza Bio

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Granza Bio Funding FAQs

What does Granza Bio do?

Granza Bio is a company that specializes in creating cancer treatments that utilize the immune system of the human body.

How much funding has Granza Bio raised?

Granza Bio has raised $7.1M across 1 round on record. The most recent is a Seed of $7.1M announced in Jul 2024.

When did Granza Bio last raise funding?

Granza Bio's most recent funding round on record is a Seed of $7.1M, announced in Jul 2024.

Who founded Granza Bio?

FundedIQ lists Ashwin Jainarayanan (Founder) at Granza Bio.

Where is Granza Bio headquartered?

Granza Bio is based in San Francisco, California, United States.

How many employees does Granza Bio have?

Granza Bio is in the 1-10 employee band.

How does Granza Bio's funding compare to other Biotechnology startups?

Granza Bio's latest round of $7.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Granza Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Granza Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.